Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RRX✓SelectedUSD · RRXGSK vs RRX performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs RRX

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+103.1%
RRX return
+180.1%
Excess return
-77.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioRRXExcessAlpha
1D-2.3%-2.4%+0.1%-2.0%
7D-3.0%-8.3%+5.3%-2.0%
30D+0.4%+7.1%-6.7%-0.8%
3M-1.2%-5.3%+4.1%-1.0%
6M+0.9%-16.0%+17.0%+1.8%
YTD+4.0%+18.2%-14.2%-0.5%
1Y+7.3%+28.3%-21.0%+1.4%
3Y+57.1%+46.2%+10.9%+40.8%
5Y+43.0%+1.7%+41.3%+33.7%
10Y+103.1%+183.0%-79.9%+47.4%
All+103.1%+180.1%-77.1%+47.4%

Cumulative growth

Daily Returns

Daily percentage return beside RRX.

Daily Out/Under-Performance

Portfolio return minus RRX return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RRX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded RRX wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling